Eyewire Today


Archives: Acquisitions/Mergers

Show articles per page

Wednesday, September 24, 2014

Pfizer Said to Approach Actavis to Gauge Interest in Deal

From Bloomberg

Pfizer has approached Actavis Plc to express its interest in an acquisition, people with knowledge of the matter said, as the U.S. drugmaker continues to explore ways to cut its tax rate and gain a new product pipeline. ... Read full article

Monday, September 22, 2014

WSJ: Allergan in Advanced Talks to Acquire Salix Pharmaceuticals

From Eyewiretoday.com

The Wall Street Journal reported late Monday that Allergan is now back in advanced talks to buy Salix Pharmaceuticals.[1] An Allergan acquisition of Salix, likely valued at more than $10 billion in cash, could derail the... Read full article

Friday, September 19, 2014

Valeant Acquisition Provides Pipeline for Expansion of Bausch + Lomb US Sur...

From Bausch + Lomb

Bausch + Lomb announced that the agreement between Valeant and Croma, under which Valeant will distribute Croma's ophthalmology and orthopedics products in Western Europe, would also provide an opportunity to introduce a... Read full article

Tuesday, September 16, 2014

Nicox Continues European Ophthalmic Expansion in Europe with Two Acquisitio...

From Nicox S.A.

Nicox S.A. announced two acquisitions in the ophthalmic market as it continues to expand its European presence. Nicox has acquired 100% of the shares of Doliage, a privately-held French ophthalmic company, for 5 mil... Read full article

Tuesday, September 16, 2014

Allergan to Hold Special Meeting of Stockholders on Originally Scheduled Da...

From Allergan

Allergan announced that it has reached an agreement with Pershing Square Capital Management and Valeant Pharmaceuticals under which Allergan will hold the special meeting of stockholders on the originally scheduled date ... Read full article

Friday, September 05, 2014

Allergan Approves Requests to Call a Special Meeting

From Eyewiretoday.com

Allergan announced that Pershing Square Capital Management's requests from more than 25% of Allergan shareholders - the amount needed to call a special meeting - are valid and comply with Allergan's bylaws. Therefore, Al... Read full article

Thursday, September 04, 2014

Google Joins AbbVie in $1.5 Billion Aging Disease Effort

From Bloomberg

AbbVie Inc., the drugmaker spun off from Abbott Laboratories last year, and Googles Calico will spend as much as $1.5 billion to tackle age-related diseases, including cancer and neurodegenerative disorders. Calico will ... Read full article

Tuesday, September 02, 2014

Beaver-Visitec International Announces Purchase of Endo Optiks

From Beaver-Visitec International Inc.

Beaver-Visitec International announced the purchase of Endo Optiks, which treats glaucoma and retinal diseases via minimally invasive endoscopy, according to a company news release. Terms of the deal were not disclosed. ... Read full article

Thursday, August 28, 2014

Valeant, Ackman get October 6 Trial Over Allergan Special Meeting

From Reuters

Valeant Pharmaceuticals International and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $50 billi... Read full article

Wednesday, August 27, 2014

Alcon to Acquire WaveTec Vision, Developer of ORA Intraoperative Guidance S...

From Alcon

Alcon announced that the company has entered into an agreement to acquire privately held WaveTec Vision, the developer of the ORA System, the first commercialized intraoperative guidance system, according to a company ne... Read full article

Wednesday, August 27, 2014

Allergan to Hold Special Shareholder Meeting in December

From FirstWord

Allergan revealed Tuesday that it will hold a special shareholder meeting, during which William Ackman's Pershing Square Capital Management will seek to replace six members of the company's board, on December 18. The ann... Read full article

Tuesday, August 26, 2014

Allergan Receives Written Requests from Pershing Square Regarding Special M...

From Allergan

Allergan confirmed that Pershing Square Capital Management has delivered written requests from Allergan stockholders in connection with Pershing Square's request to call a special meeting of stockholders, according to a ... Read full article

Monday, August 25, 2014

Valeant Says Allergan Investors Demand Meeting on Deal

From Bloomberg

Valeant and Pershing Square Capital Management said 31% of Allergans shareholders support their effort to call a special meeting as part of Valeants $54 billion takeover bid for the maker of the Botox anti-wrinkle cream.... Read full article

Monday, August 25, 2014

Roche Holding Agrees to Buy InterMune for $8.3 Billion

From Bloomberg

Roche Holding AG agreed to buy InterMune Inc. for about $8.3 billion in cash, gaining access to what may be the first drug in the U.S. for a lung disease that can be fatal within five years of diagnosis. Roche will pay $... Read full article

Friday, August 22, 2014

Allergan Talks to Buy Salix in Defense Move Said to Be Dormant

From Bloomberg

Allergan isnt currently in active talks to acquire Salix Pharmaceuticals Ltd., people with knowledge of the matter said, though the drugmakers have discussed a deal. Allergan, seeking to stave off a hostile bid from Vale... Read full article

Thursday, August 21, 2014

Could Buying Salix Get Valeant off of Allergan's Scent?

From Fierce Biotech

Allergan, working to fend off a hostile approach from Valeant Pharmaceuticals, is reportedly taking a look at the smaller Salix Pharmaceuticals, weighing a multibillion-dollar deal that could render it unattainable--or a... Read full article

Wednesday, August 20, 2014

WSJ: Allergan Contacted Salix Pharmaceuticals About Possible Takeover

From Eyewiretoday.com

According to a report in the Wall Street Journal, Allergan has approached Salix Pharmaceuticals about a potential acquisition that could thwart the $53 billion hostile bid for Allergan by Valeant, according to people fam... Read full article

Monday, August 18, 2014

Valeant Extends Tender Offer for Allergan Until Year End

From Bloomberg

Valeant said it extended its offer to purchase Allergan until the end of the year, after an initial deadline for its tender offer was scheduled to expire today. Valeant has joined with the hedge fund Pershing Square Capi... Read full article

Friday, August 15, 2014

Pershing Says It Welcomes SEC Review of Allergan Bid

From Bloomberg

Pershing Square Capital Management LP, which teamed with Valeant to bid for Allergan, said it welcomes a U.S. Securities and Exchange Commission review of its takeover tactics and defended them. There is nothing illegal,... Read full article

Thursday, August 14, 2014

SEC Reportedly Investigating Valeant, Pershing Square's Hostile Takeover Bi...

From Eyewiretoday.com

According to a report in the Wall Street Journal, the US Securities and Exchange Commission has launched a civil probe into Valeant Pharmaceuticals and Pershing Square Capital Management's joint takeover attempt for Alle... Read full article


Featured Jobs
  • Cornea Specialist

    MA (Statewide)

    Cornea Specialist, Massachusetts Multi-physician/multi-Subspecialty/multi-Location practice in central Massachusetts (just west of Boston) is seeking a board-certified/board-eligible cornea specialist to join their estab...

Featured Events